By Notice dated September 28, 2004 and published in the Federal Register on October 14, 2004, (69 FR 61044), Cerilliant Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78664, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in Schedules I and II:
|Gamma hydroxybutyric acid (2010)||I|
|Start Printed Page 10678|
|Dextropropoxyphene, bulk (non-dosage forms) (9273)||II|
The company plans to import small quantities of the listed controlled substances for the manufacture of analytical reference standards.
No comments or objections have been received. DEA has considered the factors in 21 U.S.C. sections 823(a) and 952(a) and determined that the registration of Cerilliant Corporation to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Cerilliant Corporation to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. sections 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic class of controlled substance listed.Start Signature
Dated: February 22, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. 05-4234 Filed 3-3-05; 8:45 am]
BILLING CODE 4410-09-P